GLPG Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 birž. 2024 @ 16:30):
Our systems believe the stock currently is overvalued by -1.09% compare to its pairs and should correct downwards.

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need...

Stats
Šios dienos apimtis	2 083
Vidutinė apimtis	120 801
Rinkos kapitalizacija	1.71B
EPS	$1.370 ( Q1 \| 2024-05-03 )
Kita pelno data	( $0.110 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	51.96 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0160 (0.06%)

AADI 0.00%

ABCL 0.98%

ABCM 0.04%

ABEO 0.22%

ABIO 2.17%

ABOS -0.40%

ABSI 0.00%

ABUS 0.33%

ABVX -0.22%

ACAD 0.84%

ACER -17.95%

ACET 0.38%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP -0.93%

ADGI 0.87%

ADIL -1.57%

ADMA 0.25%

ADPT -0.96%

ADTX -1.27%

ADVM -0.07%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -1.89%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.26%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 1.90%

ALEC 0.44%

ALGS -0.25%

ALKS 0.34%

ALLK -0.85%

ALLO -0.67%

ALLR -2.32%

ALNA 3.16%

ALNY -0.01%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -0.34%

ALVR 0.60%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -0.52%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.15%

ANL 0.61%

ANNX -0.65%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 10.18%

APLS 0.78%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.44%

ARDS 20.48%

ARDX 0.00%

ARGX 0.19%

ARNA 0.00%

ARPO -0.90%

ARQT -1.51%

ARTL -4.55%

ARTLW 9.80%

ARVN -0.60%

ARWR -0.44%

ASLN 2.75%

ASMB -0.86%

ASND 0.41%

ATAI 0.37%

ATHA -0.38%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 0.87%

ATRA -2.10%

ATXI -1.66%

ATXS 0.45%

AUPH -0.36%

AURA 0.68%

AUTL -0.23%

AVBP -0.27%

AVEO 0.00%

AVIR -0.28%

AVRO -2.05%

AVTE -4.26%

AVTX 4.15%

AVXL 0.00%

AXLA 0.00%

AXSM 0.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.44%

BCAB 1.92%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI -0.73%

BCRX -1.44%

BCTX -0.68%

BCTXW 0.00%

BCYC 1.49%

BDRX 1.05%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -1.47%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -1.19%

BMEA -0.39%

BMRN 0.40%

BNOX -3.57%

BNTC 2.46%

BNTX -0.16%

BOLD 0.49%

BOLT -0.50%

BPMC 0.12%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -9.80%

BTAI 0.75%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.00%

CABA -1.41%

CADL -1.11%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -0.60%

CARA 2.85%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.61%

CCCC -1.09%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.40%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.18%

CDXS -1.51%

CELC 0.99%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.07%

CERO -4.29%

CEROW -44.78%

CFRX -27.95%

CGEM -1.87%

CGEN -1.02%

CGON -0.59%

CGTX 1.37%

CHMA -6.00%

CHRS -0.01%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 2.83%

CLGN 0.30%

CLLS -6.54%

CLNN 0.37%

CLNNW -41.25%

CLRB 0.74%

CLSD 0.86%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 3.65%

CMPI 0.00%

CMPX 0.00%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.11%

CNCE 0.00%

CNSP -5.00%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT -0.28%

COYA 2.22%

CPRX 0.00%

CRBP -2.67%

CRBU -0.57%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.55%

CRSP 0.10%

CRTX 2.63%

CRVO 1.97%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 2.16%

CTNM -2.94%

CTXR 1.43%

CUE -0.75%

CVAC 0.86%

CVKD 1.37%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.37%

CYTO -3.23%

DARE 1.19%

DAWN 0.54%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 1.12%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.26%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 4.14%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM 0.52%

ENGN -3.89%

ENGNW -5.29%

ENLV 0.73%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 3.24%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.49%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB -0.45%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI 0.00%

EXEL -0.30%

EYEG -0.43%

EYEN -0.33%

EYPT -1.33%

FATE 0.42%

FBIO 0.53%

FBIOP 1.09%

FBLG -1.17%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.47%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD -0.20%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC 0.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.38%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -0.96%

GHRS 3.42%

GLMD -3.30%

GLPG 0.93%

GLSI -2.51%

GLTO 0.00%

GLUE 0.00%

GLYC 2.57%

GMAB 0.95%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 11.38%

GOVX 18.92%

GOVXW -24.72%

GPCR 0.40%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.38%

GUTS 0.28%

GXGXW 41.67%

GYRE 0.17%

HALO -0.01%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.56%

HOTH -3.73%

HOWL -1.27%

HRMY 0.00%

HRTX 1.66%

HSTO 62.16%

HUMA 1.78%

HUMAW -5.97%

IBRX 0.85%

ICCC 2.84%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -1.10%

IMCR -0.81%

IMGN 0.02%

IMGO 0.00%

IMMP 1.15%

IMMX -0.49%

IMNM -0.46%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.32%

IMTX -0.85%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT 0.11%

INAB -0.02%

INBX -0.35%

INCY 0.34%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 1.46%

INMB -0.60%

INO 0.00%

INSM -0.40%

INTS 0.84%

INVA 1.55%

INZY 0.44%

IOBT -0.81%

IONS -0.37%

IOVA -0.12%

IPA 0.00%

IPHA -10.64%

IPSC 0.95%

IRON -1.08%

ISEE 0.38%

ITOS -0.84%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX -0.26%

JANX -0.13%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.08%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -5.56%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD 0.00%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -1.56%

KRRO -0.63%

KRTX 0.03%

KRYS -0.18%

KTRA 8.99%

KTTA -2.85%

KTTAW 8.62%

KURA 1.02%

KYMR -0.38%

KYTX 0.70%

KZIA 8.44%

KZR 0.65%

LABP 0.57%

LBPH -0.98%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX 2.73%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -12.50%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 2.99%

LPTX -0.25%

LQDA -0.23%

LRMR 1.19%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX 0.87%

LYEL -0.45%

LYRA -1.26%

MACK 0.00%

MBIO 32.67%

MBRX -4.83%

MCRB -1.60%

MDGL 0.06%

MDNA -13.16%

MDWD 1.00%

MDXG 0.15%

MEIP 1.41%

MESO 2.07%

MGNX -3.01%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 1.00%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.25%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD 0.00%

MNMD 1.14%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.55%

MORF 1.34%

MREO 0.00%

MRKR -4.76%

MRNA -1.21%

MRNS 2.07%

MRSN 0.00%

MRTX -0.17%

MRUS -1.24%

MRVI 0.28%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS 3.25%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -6.05%

NCNA -1.64%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.95%

NKGN 0.78%

NKGNW 39.76%

NKTR -2.14%

NKTX -1.89%

NLSP 147.56%

NLSPW 6.21%

NMRA 1.29%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 4.28%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA 0.00%

NTRBW -6.25%

NUVL -0.03%

NVAX -0.75%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -0.47%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -2.99%

OCGN 3.68%

OCS -1.09%

OCUL -0.36%

OCUP 0.00%

ODT -4.27%

OKYO 0.00%

OLMA -0.47%

OMER 0.87%

OMGA 5.65%

ONCO 18.82%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.26%

OVID -3.75%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX -0.73%

PDSB -0.37%

PEPG 0.70%

PGEN 0.61%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 6.80%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.27%

PLUR 0.00%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 5.56%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK 1.03%

PRQR -1.76%

PRTA 0.34%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 0.00%

QLGN 19.02%

QNCX -1.41%

QNRX 3.04%

QSI 1.13%

QSIAW 0.00%

QTTB 0.00%

QURE -0.43%

RAIN -1.63%

RANI 0.00%

RAPT -0.30%

RARE -1.56%

RCKT 0.19%

REGN 0.06%

RENB -1.89%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.40%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.12%

RIGL 2.00%

RLAY 0.70%

RLMD 0.00%

RLYB 0.00%

RNA -1.02%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.45%

ROIV 0.37%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.68%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC -0.36%

RVPH -0.68%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.32%

RYTM 0.46%

RYZB 0.02%

RZLT 0.00%

SABS -2.75%

SABSW -32.14%

SAGE 0.71%

SANA -0.17%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -10.34%

SCPH 0.00%

SCPS 0.00%

SEEL -1.16%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -3.29%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 5.16%

SLS -3.04%

SMMT -0.25%

SNDX 0.13%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.55%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.94%

STSA 0.00%

STTK 0.40%

SURF -0.93%

SVRA -0.78%

SWTX -3.64%

SYBX -0.63%

SYRS -2.63%

TALS -0.73%

TARA 0.41%

TARS 1.72%

TBPH -0.12%

TCBP 1.78%

TCDA 0.00%

TCON -1.47%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN 0.13%

TFFP -2.05%

TGTX 0.21%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX 0.43%

TNXP 0.67%

TNYA 0.00%

TPST 0.52%

TRDA -3.61%

TRVI -0.18%

TRVN -1.88%

TSHA -9.93%

TSVT 0.25%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -7.01%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.08%

VERU 0.50%

VERV -1.33%

VIGL -2.75%

VINC 1.05%

VIR -0.87%

VIRI -5.41%

VIRX -6.84%

VKTX -0.50%

VLON -13.04%

VNDA 0.63%

VOR 0.85%

VRCA 0.00%

VRDN -0.74%

VRNA 0.00%

VRPX -14.72%

VRTX 0.03%

VSTM 0.29%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 7.87%

VYGR 0.10%

VYNE 2.16%

VYNT 7.78%

WINT 5.59%

WVE -0.67%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE 0.30%

XERS 0.00%

XFOR -0.54%

XLO 2.96%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.88%

YMAB -0.38%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.20%

ZNTL -25.48%

ZSAN 0.00%

Koreliacija (AI algo v.1.1b): Overvalued: -1.09% $26.02 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.04 (neutral)

Trumpas: -0.51 (weak negative)

Signal:(71.014) Neutral

Galapagos NV Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
SIRI	0.971
FXNC	0.958
APTO	0.957
BPTH	0.956
PACB	0.955
HTLD	0.955
AKTX	0.954
PRTS	0.954
NLSP	0.954
ARKO	0.953

10 Labiausiai neigiamai susiję koreliacijos
SWAV	-0.97
PPC	-0.968
PNTG	-0.967
RZLT	-0.955
ENTX	-0.949
FANG	-0.949
TCOM	-0.947
APP	-0.946
ARYD	-0.945
FRLA	-0.944

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Galapagos NV Koreliacija - Valiuta/Žaliavos

-0.33
( neutral )

-0.59
( weak negative )

0.00
( neutral )

-0.12
( neutral )

0.03
( neutral )

0.28
( neutral )

Galapagos NV Finansinės ataskaitos

Annual	2023
Pajamos:	$239.72M
Bruto pelnas:	$239.70M (99.99 %)
EPS:	$3.21

FY	2023
Pajamos:	$239.72M
Bruto pelnas:	$239.70M (99.99 %)
EPS:	$3.21

FY	2022
Pajamos:	$505.28M
Bruto pelnas:	$493.20M (97.61 %)
EPS:	$-3.32

FY	2021
Pajamos:	$484.85M
Bruto pelnas:	$483.22M (99.66 %)
EPS:	$-1.580

Financial Reports:

No articles found.

Galapagos NV Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Galapagos NV

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.